​

Phreesia (PHR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PHR Stock Forecast

Phreesia (PHR) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $34.80, with a high of $38.00 and a low of $33.00. This represents a 36.58% increase from the last price of $25.48.

$15 $20 $25 $30 $35 $40 High: $38 Avg: $34.8 Low: $33 Last Closed Price: $25.48

PHR Stock Rating

Phreesia stock's rating consensus is Buy, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 21 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 21 0 21 Strong Sell Sell Hold Buy Strong Buy

PHR Price Target Upside V Benchmarks

TypeNameUpside
StockPhreesia36.58%
SectorHealthcare Stocks 13.55%
IndustryHealthcare Information Services Stocks 11.31%

Price Target Trends

1M3M12M
# Anlaysts557
Avg Price Target$34.80$34.80$33.71
Last Closing Price$25.48$25.48$25.48
Upside/Downside36.58%36.58%32.30%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 25511---16
Aug, 25510---15
Jul, 25510---15
Jun, 25510---15
May, 2559---14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 08, 2025Aaron KimsonJMP Securities$34.00$26.7826.96%33.44%
Sep 05, 2025Truist Financial$36.00$28.1327.98%41.29%
Sep 05, 2025Raymond James$33.00$28.1317.31%29.51%
Sep 05, 2025D.A. Davidson$33.00$28.1317.31%29.51%
Sep 05, 2025Richard CloseCanaccord Genuity$38.00$28.1335.09%49.14%
Dec 11, 2024Joe VruwinkRobert W. Baird$30.00$24.7821.07%17.74%
Nov 29, 2024Gil LuriaD.A. Davidson$32.00$20.4256.71%25.59%
Sep 06, 2024Jailendra SinghTruist Financial$31.00$25.6920.67%21.66%
Sep 06, 2024Joe VruwinkRobert W. Baird$34.00$25.6932.35%33.44%
Sep 05, 2024Sean WielandPiper Sandler$30.00$25.6916.78%17.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 08, 2025CitigroupOutperformOutperformhold
Sep 05, 2025Raymond JamesOutperformOutperformhold
Sep 05, 2025NeedhamBuyBuyhold
Sep 05, 2025Piper SandlerOverweightOverweighthold
May 28, 2025CitigroupBuyBuyhold
Jan 10, 2025CitigroupBuyBuyhold
Jan 08, 2025KeyBancOverweightOverweighthold
Sep 27, 2024Truist FinancialSector PerformSector Performhold
Sep 05, 2024Piper SandlerOverweightOverweighthold
Sep 05, 2024Canaccord GenuityBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Jan 21 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28 Jan 29
Jan 21Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28Jan 29
Reported$-0.69$-2.37$-3.36$-2.51$-1.02----
Avg Forecast$-0.66$-2.49$-3.41$-2.52$-1.09$-0.29$0.18$0.72$0.24
High Forecast$-0.64$-2.42$-3.39$-1.30$-1.02$-0.17$0.90$0.73$0.24
Low Forecast$-0.67$-2.54$-3.42$-2.78$-1.15$-0.46$-0.46$0.72$0.24
Surprise %4.55%-4.82%-1.47%-0.40%-6.42%----

Revenue Forecast

$100M $210M $320M $430M $540M $650M Jan 21 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28 Jan 29
Jan 21Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28Jan 29
Reported$148.68M$213.23M$280.91M$356.30M$419.81M----
Avg Forecast$146.52M$211.47M$278.86M$354.83M$419.04M$476.60M$533.23M$586.36M$646.80M
High Forecast$148.60M$214.47M$279.63M$355.42M$420.20M$477.84M$533.47M$587.98M$648.59M
Low Forecast$143.44M$207.02M$277.70M$354.36M$417.97M$474.21M$532.98M$583.92M$644.12M
Surprise %1.47%0.83%0.73%0.41%0.18%----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Jan 21 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28 Jan 29
Jan 21Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28Jan 29
Reported$-27.29M$-118.16M$-176.15M$-136.88M$-58.53M----
Avg Forecast$-36.09M$-64.28M$-186.11M$-144.26M$-62.51M$-18.16M$6.95M$39.47M$13.09M
High Forecast$-35.10M$-51.43M$-185.10M$-115.41M$-55.55M$-9.17M$49.26M$39.61M$13.14M
Low Forecast$-36.75M$-77.14M$-186.78M$-173.11M$-62.56M$-25.02M$-24.96M$39.25M$13.02M
Surprise %-24.37%83.81%-5.35%-5.11%-6.38%----

PHR Forecast FAQ

Is Phreesia stock a buy?

Phreesia stock has a consensus rating of Buy, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 21 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Phreesia is a favorable investment for most analysts.

What is Phreesia's price target?

Phreesia's price target, set by 21 Wall Street analysts, averages $34.8 over the next 12 months. The price target range spans from $33 at the low end to $38 at the high end, suggesting a potential 36.58% change from the previous closing price of $25.48.

How does Phreesia stock forecast compare to its benchmarks?

Phreesia's stock forecast shows a 36.58% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the healthcare information services stocks industry (11.31%).

What is the breakdown of analyst ratings for Phreesia over the past three months?

  • September 2025: 31.25% Strong Buy, 68.75% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Phreesia’s EPS forecast?

Phreesia's average annual EPS forecast for its fiscal year ending in January 2026 is $-0.29, marking a -71.57% decrease from the reported $-1.02 in 2025. Estimates for the following years are $0.18 in 2027, $0.72 in 2028, and $0.24 in 2029.

What is Phreesia’s revenue forecast?

Phreesia's average annual revenue forecast for its fiscal year ending in January 2026 is $476.6M, reflecting a 13.53% increase from the reported $419.81M in 2025. The forecast for 2027 is $533.23M, followed by $586.36M for 2028, and $646.8M for 2029.

What is Phreesia’s net income forecast?

Phreesia's net income forecast for the fiscal year ending in January 2026 stands at $-18.159M, representing a -68.97% decrease from the reported $-58.527M in 2025. Projections indicate $6.95M in 2027, $39.47M in 2028, and $13.09M in 2029.